Tan K C, Shiu S W, Kung A W
Department of Medicine, University of Hong Kong, Hong Kong.
J Clin Endocrinol Metab. 1998 Aug;83(8):2921-4. doi: 10.1210/jcem.83.8.4938.
To investigate the effect of thyroid dysfunction on high-density lipoprotein (HDL) metabolism, we measured HDL subfractions, apolipoprotein A-I containing particles (LpA-I and LpA-I:A-II), and the activities of enzymes involved in the remodeling and metabolism of HDL [namely hepatic lipase (HL), lipoprotein lipase, and cholesteryl ester transfer protein (CETP)] in 18 hyperthyroid and 17 hypothyroid patients before and after treatment. HDL was subfractionated by density gradient ultracentrifugation, and LpA-I was analyzed by electroimmunodiffusion. The major changes were found in the HDL2 subfraction and in LpA-I particles. HDL2-C and LpA-I were reduced in hyperthyroidism (P < 0.01, P < 0.05, respectively) and increased in hypothyroidism (both P < 0.05) compared with their respective euthyroid matched controls. Changes in HDL2-cholesterol were reversed after treatment in both hyper- and hypothyroid patients, and LpA-I also decreased in the hypothyroid patients after treatment. HL (P < 0.05) and CETP activities (P < 0.05) were elevated in hyperthyroidism and reduced in hypothyroidism (P < 0.05, P < 0.01 respectively) and both were related to free T4 levels. The changes in HDL2-C and LpA-I correlated significantly with changes in HL after treatment but not with CETP or lipoprotein lipase. In summary, HDL metabolism was altered in thyroid dysfunction, and the effect of thyroid hormone on HDL was mediated mainly via its effect on HL activity.
为研究甲状腺功能障碍对高密度脂蛋白(HDL)代谢的影响,我们测定了18例甲亢患者和17例甲减患者治疗前后的HDL亚组分、含载脂蛋白A-I的颗粒(LpA-I和LpA-I:A-II)以及参与HDL重塑和代谢的酶[即肝脂酶(HL)、脂蛋白脂肪酶和胆固醇酯转运蛋白(CETP)]的活性。HDL通过密度梯度超速离心进行亚组分分离,LpA-I通过电免疫扩散进行分析。主要变化见于HDL2亚组分和LpA-I颗粒。与各自的甲状腺功能正常匹配对照组相比,HDL2-C和LpA-I在甲亢时降低(分别为P < 0.01,P < 0.05),在甲减时升高(均为P < 0.05)。甲亢和甲减患者治疗后HDL2-胆固醇的变化均逆转,甲减患者治疗后LpA-I也降低。HL活性(P < 0.05)和CETP活性(P < 0.05)在甲亢时升高,在甲减时降低(分别为P < 0.05,P < 0.01),且均与游离T4水平相关。治疗后HDL2-C和LpA-I的变化与HL活性的变化显著相关,但与CETP或脂蛋白脂肪酶无关。总之,甲状腺功能障碍时HDL代谢发生改变,甲状腺激素对HDL的影响主要通过其对HL活性的作用介导。